Pharmacokinetics of ofloxacin in patients with multidrug-resistant tuberculosis

Seung Kyu Park, Young Ran Yoon, Woo Chul Lee, Hyung Min Jun, Ji Hong Shon, Kyoung Ah Kim, Ji Young Park, Jae Gook Shin

Research output: Contribution to journalArticle

2 Citations (Scopus)


Background: There are few studies that have reported on the pharmacokinetic(PK) disposition of fluoroquinolones in patients with multi-drug resistant tuberculosis (MDR-Tb), even though fluoroquinolones are frequently co-prescribed to those patients. In this study, the PK disposition of ofloxacin, a fluoroquinolone, was evaluated in patients with MDR-Tb. Methods: Twenty patients with MDR-Tb were given 2nd line Tb drugs including ofloxacin (300mg twice a day), prothionamide, cycloserine, para-aminosalicylic acid, kanamycin, and streptomycin. The patients were grouped according to their body mass index(BMI) as an index of emaciation (group A: 18.5≤BMI<23, group B: BMI<18.5). Blood samples were serially drawn and urine samples were collected upto 24 hours after the last dose of those drugs at steady state (over 1 month). The ofloxacin concentrations were determined using HPLC (High Performance Liquid Chromatography). Results: The AUC of ofloxacin in group B was greater than that in group A (31.4±8.9μg/ml·h vs. 24.1± 6.2μg/ml·h) (Check the symbols), (p<0.05). The total clearance (Cl/F) of ofloxacin was 0.16±0.03 L/h/kg in group A, and 0.14±0.03 L/h/kg in group B. The half-lives of ofloxacin in two groups were similar (group A: 5.3±0.8 hours, group B: 5.7±0.9 hours). In addition, the other PK parameters in two groups were also similar. Conclusions: The pharmacokinetics of ofloxacin in patients with MDR-Tb appears to be comparable with those of normal subjects, and the extent of emaciation appears to have an influence on the pharmacokinetics of ofloxaicn in chronic debilitated MDR-Tb patients.

Original languageEnglish
Pages (from-to)128-136
Number of pages9
JournalTuberculosis and Respiratory Diseases
Issue number2
Publication statusPublished - 2002


  • BMI
  • MDR-Tb
  • Ofloxacin
  • Pharmacokinetics

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Pharmacokinetics of ofloxacin in patients with multidrug-resistant tuberculosis'. Together they form a unique fingerprint.

  • Cite this

    Park, S. K., Yoon, Y. R., Lee, W. C., Jun, H. M., Shon, J. H., Kim, K. A., Park, J. Y., & Shin, J. G. (2002). Pharmacokinetics of ofloxacin in patients with multidrug-resistant tuberculosis. Tuberculosis and Respiratory Diseases, 52(2), 128-136.